Athanasios Karampeazis

492 total citations
26 papers, 317 citations indexed

About

Athanasios Karampeazis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Athanasios Karampeazis has authored 26 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Athanasios Karampeazis's work include Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Athanasios Karampeazis is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Athanasios Karampeazis collaborates with scholars based in Greece, United Kingdom and United States. Athanasios Karampeazis's co-authors include Lambros Vamvakas, Vassilis Georgoulias, Sofia Agelaki, John Souglakos, Αthanasios Kotsakis, L. Vamvakas, Athanasios Pallis, Alexandra Voutsina, V. Georgoulias and George Samonis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Athanasios Karampeazis

22 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athanasios Karampeazis Greece 10 245 221 25 25 23 26 317
Mitsuru Yanagaki Japan 11 143 0.6× 56 0.3× 86 3.4× 14 0.6× 34 1.5× 48 261
J.W.G. van Putten Netherlands 9 225 0.9× 229 1.0× 29 1.2× 45 1.8× 67 2.9× 11 402
Jacky Créquit France 9 229 0.9× 306 1.4× 47 1.9× 14 0.6× 39 1.7× 18 368
Sujay Srinivas India 9 122 0.5× 80 0.4× 58 2.3× 24 1.0× 27 1.2× 36 251
Jeffrey T. Yorio United States 8 193 0.8× 136 0.6× 70 2.8× 14 0.6× 30 1.3× 22 323
Giuseppina Arcangeli Italy 7 227 0.9× 101 0.5× 69 2.8× 23 0.9× 35 1.5× 11 336
Rajiv Panikkar United States 7 97 0.4× 43 0.2× 21 0.8× 47 1.9× 33 1.4× 14 258
Sylvie Kirscher France 6 103 0.4× 74 0.3× 12 0.5× 33 1.3× 10 0.4× 13 168
Francesco Cortiula Italy 10 202 0.8× 170 0.8× 35 1.4× 6 0.2× 51 2.2× 38 324
Élizabeth Fabre-Guillevin France 8 106 0.4× 121 0.5× 21 0.8× 19 0.8× 52 2.3× 18 264

Countries citing papers authored by Athanasios Karampeazis

Since Specialization
Citations

This map shows the geographic impact of Athanasios Karampeazis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Karampeazis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Karampeazis more than expected).

Fields of papers citing papers by Athanasios Karampeazis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Karampeazis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Karampeazis. The network helps show where Athanasios Karampeazis may publish in the future.

Co-authorship network of co-authors of Athanasios Karampeazis

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Karampeazis. A scholar is included among the top collaborators of Athanasios Karampeazis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Karampeazis. Athanasios Karampeazis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Fiste, Oraianthi, et al.. (2020). Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma. Cureus. 12(12). e12262–e12262. 2 indexed citations
5.
Souglakos, John, Nikolaos Kentepozidis, Athanasios Karampeazis, et al.. (2018). Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG). Journal of Geriatric Oncology. 10(1). 143–148. 7 indexed citations
6.
7.
Karampeazis, Athanasios, Lambros Vamvakas, Nikolaos Kentepozidis, et al.. (2016). Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non–Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group. Clinical Lung Cancer. 17(6). 543–549. 10 indexed citations
8.
Nicolatou‐Galitis, Ourania, Evangelia Razis, Dimitra Galiti, et al.. (2015). Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 120(6). 699–706. 25 indexed citations
9.
10.
Karampeazis, Athanasios, Alexandra Voutsina, John Souglakos, et al.. (2013). Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study. Cancer. 119(15). 2754–2764. 90 indexed citations
11.
Pallis, Athanasios, Athanasios Karampeazis, L. Vamvakas, et al.. (2011). Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group. Annals of Oncology. 22(11). 2448–2455. 12 indexed citations
12.
Boukovinas, Ioannis, Nikolaos Androulakis, Nikolaos Kentepozidis, et al.. (2011). Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Cancer Chemotherapy and Pharmacology. 69(2). 351–356. 4 indexed citations
13.
Karampeazis, Athanasios, Lambros Vamvakas, Athina Agelidou, et al.. (2011). Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study. Clinical Lung Cancer. 12(3). 155–160. 17 indexed citations
14.
Karampeazis, Athanasios, L. Vamvakas, Sofia Agelaki, et al.. (2011). Baseline comprehensive geriatric assessment (CGA) and prediction of toxicity in elderly non-small cell lung cancer (NSCLC) patients receiving chemotherapy.. Journal of Clinical Oncology. 29(15_suppl). e19656–e19656. 5 indexed citations
15.
16.
Vamvakas, L., Sofia Agelaki, Athanasios Karampeazis, et al.. (2010). Pemetrexed (MTA) compared with erlotinib (ERL) in pretreated patients with advanced non-small cell lung cancer (NSCLC): Results of a randomized phase III Hellenic Oncology Research Group trial.. Journal of Clinical Oncology. 28(15_suppl). 7519–7519. 35 indexed citations
17.
Vamvakas, L., A. Athanasiadis, Athanasios Karampeazis, et al.. (2009). Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG). Critical Reviews in Oncology/Hematology. 76(1). 61–70. 28 indexed citations
18.
Vamvakas, Lambros, Emmanouil Saloustros, Athanasios Karampeazis, & Vassilis Georgoulias. (2009). Advanced Non–Small-Cell Lung Cancer in the Elderly. Clinical Lung Cancer. 10(3). 158–167. 8 indexed citations
19.
Saridaki, Zacharenia, V. Bozionelou, Nikolaos Kentepozidis, et al.. (2007). A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors. Oncology. 72(1-2). 45–50. 2 indexed citations
20.
Kalykaki, A., L. Vamvakas, Sofia Agelaki, et al.. (2006). A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors. Oncology. 71(3-4). 197–203. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuru Yanagaki Breakdown of academic impact, for papers by J.W.G. van Putten Breakdown of academic impact, for papers by Jacky Créquit Breakdown of academic impact, for papers by Sujay Srinivas Breakdown of academic impact, for papers by Jeffrey T. Yorio Breakdown of academic impact, for papers by Giuseppina Arcangeli Breakdown of academic impact, for papers by Rajiv Panikkar Breakdown of academic impact, for papers by Sylvie Kirscher Breakdown of academic impact, for papers by Francesco Cortiula Breakdown of academic impact, for papers by Élizabeth Fabre-Guillevin
Rankless by CCL
2026